Enhabit Advances Kinderhook Acquisition With Antitrust Clearance

Enhabit, Inc ( (EHAB) ) has issued an update.

Enhabit, Inc., a leading home health and hospice care provider, operates in the U.S. post-acute healthcare sector, offering in-home clinical and end-of-life services supported by referral partners and payors. Its NYSE-listed platform has made it a strategic target for private equity funds seeking exposure to demographic-driven growth in home-based care and hospice services.

On April 15, 2026, Enhabit received early termination of the Hart-Scott-Rodino antitrust waiting period for its planned acquisition by Anchor Parent, LLC, an affiliate of funds advised by Kinderhook Industries, clearing a key regulatory hurdle for the merger first agreed on February 22, 2026. The company set a special stockholder meeting for May 12, 2026, to vote on the merger, expects closing in the second quarter of 2026 subject to remaining conditions, and has suspended earnings calls, guidance and its second-quarter 2026 earnings release, signaling a near-term shift in focus from public-market reporting to completion of the transaction.

The most recent analyst rating on (EHAB) stock is a Hold with a $13.80 price target. To see the full list of analyst forecasts on Enhabit, Inc stock, see the EHAB Stock Forecast page.

Spark’s Take on EHAB Stock

According to Spark, TipRanks’ AI Analyst, EHAB is a Neutral.

EHAB scores moderately due to improving financial performance (better profitability trajectory and strong free cash flow) as the primary driver, supported by a bullish technical trend. The score is held back by loss-driven valuation signals (negative P/E) and the need for sustained net profitability, while corporate events (take-private agreement and credit extension) provide additional support but carry closing/approval risk.

To see Spark’s full report on EHAB stock, click here.

More about Enhabit, Inc

Enhabit, Inc. is a leading U.S. home health and hospice care provider, operating in the post-acute healthcare sector and listed on the NYSE under the ticker EHAB. The company focuses on delivering in-home clinical and end-of-life services, positioning itself as a key player in the growing market for home-based care and hospice support across its service regions.

The business model centers on coordinated home health services and hospice programs, relying on relationships with referral partners, payors and patients. This orientation makes Enhabit sensitive to regulatory decisions, capital availability and strategic transactions, such as mergers and acquisitions, that can reshape its ownership structure and operational priorities.

The company’s scale and specialization in home-based care make it a strategic target for private equity-backed buyers seeking exposure to aging demographics and the shift away from facility-based care. Its operations and investor communications are therefore closely tied to transaction milestones and regulatory clearances that can materially affect its trajectory.

Average Trading Volume: 1,482,350

Technical Sentiment Signal: Buy

Current Market Cap: $695.4M

For detailed information about EHAB stock, go to TipRanks’ Stock Analysis page.